Windlas Biotech Ltd

WINDLAS06 Dec 2024
Pharmaceuticals
+57.55 (+5.30%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Windlas Biotech Ltd
Windlas Biotech Ltd
Pharmaceuticals
WINDLAS06 Dec 2024
+57.55 (+5.30%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Windlas Biotech Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
174.24%
Upper Circuit
Lower Circuit
P/E TTM
39.04
P/B Ratio
5.06
Traded Value(Cr)
0.00
EPS TTM
29.27
Book value
Dividend
0.48%

Invest in Windlas Biotech Ltd at ZERO Brokerage for 30 days

Price Performance

4.67 %
1 Wk
1.39 %
1 M
26.97 %
3 M
174.24 %
1 Y
140.14 %
YTD

Traded Volume Movement

Technical Details

Support 3
1032
Support 2
1063
Support 1
1104
Pivot Point :
1135
Resistance 1
1176
Resistance 2
1206
Resistance 3
1247

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Windlas Biotech Ltd
₹1,144.25(+57.55/5.30%)
1,144.25+57.552,391.52174.2439.045.06
Lupin Ltd
₹2,133.55(+8.50/0.40%)
2,133.55+8.5097,332.0371.5832.454.43
Ipca Laboratories Ltd
₹1,538.20(+44.85/3.00%)
1,538.20+44.8539,024.7836.5555.915.79
J B Chemicals & Pharmaceuticals Ltd
₹1,763.95(-14.80/-0.83%)
1,763.95-14.8027,413.5018.2945.688.68
388.85+0.552,282.76-13.1622.841.38
Sanofi India Ltd
₹6,242.30(-39.65/-0.63%)
6,242.30-39.6514,376.02-24.0134.0820.99

About Windlas Biotech Ltd

Windlas Biotech Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 2388.38 crores. It has reported a sales of Rs. 187 crores and a net profit of Rs. 15.66 crores for the quarter ended December 2018. The company management includes Vivek Dhariwal, Vivek Dhariwal,Ashok Kumar Windlass,Hitesh Windlass,Manoj Kumar Windlass,Pawan Kumar Sharma,Prachi Jain Windlass,Srinivasan Venkataraman,Gaurav Gulati,Ananta Narayan Panda (Windlas Biotech Ltd) among others.
Chairman
Vivek Dhariwal
Registered office
40/1 Mohabewala Industrial,Area,Dehradun,Uttarakhand,248110
FAX :
Background
Incorporation Year2001
Face Value₹5
Market Lot1

Latest News

Bajaj Healthcare get approval from Australian agency for manufacturing site

Bajaj Healthcare's API manufacturing site in Savli, Vadodara, Gujarat, has received approval from the Therapeutic Goods Administration (TGA) of Australia.This site, already approved by the USFDA and the European Union, is now authorised to supply active pharmaceutical ingredients (APIs) directly to the Australian and New Zealand markets. The approval is valid for 24 months.
07 Dec 2024 | 12:44 PM

Multibagger SME IPO turns ₹1.40 lakh to ₹5.49 lakh in two years

Bonus shares, stock split effect: Investing in stocks is like investing in a business. Rhetan TMT shares, listed on the BSE SME platform in 2022, declared a 1:10 stock split and 11:4 bonus shares in 2023, resulting in a significant increase in shareholding from 2000 to 25,500, and a surge in value from ₹1.40 lakh to ₹5.49 lakh.
07 Dec 2024 | 12:01 PM

8 stocks nearing ex-dates for dividend, bonus, split next week

Shareholders who purchase the stock at least one day before the ex-date are eligible for dividends, as the settlement occurs the following day. However, those buying the stock on the ex-date will not qualify for dividends, splits, bonus issues, or similar benefits. Exxaro Tiles and other companies will be in focus next week as they approach record dates for dividends, bonus issues & stock splits.
07 Dec 2024 | 12:00 PM

Traders ramp up bets on December fed cut after mixed jobs data

US Treasuries rallied and traders boosted their bets on a Federal Reserve interest-rate reduction this month after a mixed November employment report. Yields on two-year notes, which are sensitive to central-bank policy changes, slid as much as seven basis points to around 4.08% and retained the bulk of their drop late afternoon in New York.
07 Dec 2024 | 11:28 AM

Roto Rudra wins order for Solar Pumping Solutions across different states

Roto Energy Systems Ltd. has secured over 400 orders for its newly launched Solar Submersible Pumping Systems under brand name "Roto Rudra", reinforcing its position as a key player in sustainable water management globally. The orders span Australia, South Africa, & Indian states of Chhattisgarh & Maharashtra, supporting agriculture, irrigation, & renewable energy initiatives.
07 Dec 2024 | 11:03 AM

How to buy Windlas Biotech Ltd shares on nse?

To buy Windlas Biotech Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Windlas Biotech Ltd share price today?

The Windlas Biotech Ltd shares price on nse is Rs.1144.25 today.

What is the market cap of Windlas Biotech Ltd shares on NSE ?

The company has a market capitalization of Rs.2391.52Cr

What is the PE & PB ratio of Windlas Biotech Ltd shares ?

PE is 39.04 and PB is 5.06

What is the 52 Week High and Low of Windlas Biotech Ltd shares?

Windlas Biotech Ltd stock price high: Rs.1198.25 Windlas Biotech Ltd stock price low: Rs.400.1